Spruce Biosciences Inc. (NASDAQ: SPRB) started the day on January 07, 2022, with a price decrease of -4.46% at $3.86. During the day, the stock rose to $4.02 and sunk to $3.73 before settling in for the price of $4.04 at the close. Taking a more long-term approach, SPRB posted a 52-week range of $2.25-$28.49.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -125.70%. This publicly-traded company’s shares outstanding now amounts to $23.37 million, simultaneously with a float of $4.09 million. The organization now has a market capitalization sitting at $94.80 million. At the time of writing, stock’s 50-day Moving Average stood at $3.61, while the 200-day Moving Average is $8.85.
Spruce Biosciences Inc. (SPRB) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. According to the most recent insider trade that took place on May 20, this organization’s Director sold 334 shares at the rate of 15.29, making the entire transaction reach 5,107 in total value, affecting insider ownership by 0. Preceding that transaction, on May 19, Company’s 10% Owner sold 475,000 for 13.90, making the whole transaction’s value amount to 6,602,500. This particular insider is now the holder of 4,514,336 in total.
Spruce Biosciences Inc. (SPRB) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2021, the organization reported -$0.49 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.57) by $0.08. This company achieved a return on equity of -40.30. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.63 per share during the current fiscal year.
Spruce Biosciences Inc.’s EPS decrease for this current 12-month fiscal period is -125.70% and is forecasted to reach -2.41 in the upcoming year.
Spruce Biosciences Inc. (NASDAQ: SPRB) Trading Performance Indicators
Let’s observe the current performance indicators for Spruce Biosciences Inc. (SPRB). It’s Quick Ratio in the last reported quarter now stands at 10.40. The Stock has managed to achieve an average true range (ATR) of 0.68.
In the same vein, SPRB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.79, a figure that is expected to reach -0.48 in the next quarter, and analysts are predicting that it will be -2.41 at the market close of one year from today.
Technical Analysis of Spruce Biosciences Inc. (SPRB)
If we take a close look at the recent performances of Spruce Biosciences Inc. (NASDAQ: SPRB), its last 5-days Average volume was 2.07 million that shows progress from its year to date volume of 2.07 million. During the previous 9 days, stock’s Stochastic %D was recorded 25.63% While, its Average True Range was 0.73.
Raw Stochastic average of Spruce Biosciences Inc. (SPRB) in the period of the previous 100 days is set at 25.39%, which indicates a major fall in contrast to 30.77% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 177.25% that was higher than 158.43% volatility it exhibited in the past 100-days period.